193 related articles for article (PubMed ID: 35982179)
1. Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma.
Wei Y; Qin Q; Yan C; Hayes MN; Garcia SP; Xi H; Do D; Jin AH; Eng TC; McCarthy KM; Adhikari A; Onozato ML; Spentzos D; Neilsen GP; Iafrate AJ; Wexler LH; Pyle AD; Suvà ML; Dela Cruz F; Pinello L; Langenau DM
Nat Cancer; 2022 Aug; 3(8):961-975. PubMed ID: 35982179
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
Drummond CJ; Hanna JA; Garcia MR; Devine DJ; Heyrana AJ; Finkelstein D; Rehg JE; Hatley ME
Cancer Cell; 2018 Jan; 33(1):108-124.e5. PubMed ID: 29316425
[TBL] [Abstract][Full Text] [Related]
3. High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma.
Generali M; Satheesha S; Bode PK; Wanner D; Schäfer BW; Casanova EA
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573355
[TBL] [Abstract][Full Text] [Related]
4. Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.
Danielli SG; Porpiglia E; De Micheli AJ; Navarro N; Zellinger MJ; Bechtold I; Kisele S; Volken L; Marques JG; Kasper S; Bode PK; Henssen AG; Gürgen D; Delattre O; Surdez D; Roma J; Bühlmann P; Blau HM; Wachtel M; Schäfer BW
Sci Adv; 2023 Feb; 9(6):eade9238. PubMed ID: 36753540
[TBL] [Abstract][Full Text] [Related]
5. PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.
Searcy MB; Larsen RK; Stevens BT; Zhang Y; Jin H; Drummond CJ; Langdon CG; Gadek KE; Vuong K; Reed KB; Garcia MR; Xu B; Kimbrough DW; Adkins GE; Djekidel N; Porter SN; Schreiner PA; Pruett-Miller SM; Abraham BJ; Rehg JE; Hatley ME
Nat Commun; 2023 Nov; 14(1):7291. PubMed ID: 37968277
[TBL] [Abstract][Full Text] [Related]
6. Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases.
Carrillo-Ng H; Liang Y; Chang S; Afkhami M; Gernon T; Bell D; Arias-Stella JA
Genes Chromosomes Cancer; 2023 Jul; 62(7):430-436. PubMed ID: 37057803
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
8. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
[TBL] [Abstract][Full Text] [Related]
9. The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma.
Patel AG; Chen X; Huang X; Clay MR; Komorova N; Krasin MJ; Pappo A; Tillman H; Orr BA; McEvoy J; Gordon B; Blankenship K; Reilly C; Zhou X; Norrie JL; Karlstrom A; Yu J; Wodarz D; Stewart E; Dyer MA
Dev Cell; 2022 May; 57(10):1226-1240.e8. PubMed ID: 35483358
[TBL] [Abstract][Full Text] [Related]
10. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma.
DeMartino J; Meister MT; Visser LL; Brok M; Groot Koerkamp MJA; Wezenaar AKL; Hiemcke-Jiwa LS; de Souza T; Merks JHM; Rios AC; Holstege FCP; Margaritis T; Drost J
Nat Commun; 2023 May; 14(1):3074. PubMed ID: 37244912
[TBL] [Abstract][Full Text] [Related]
12. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
13. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
Frascella E; Toffolatti L; Rosolen A
Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
[TBL] [Abstract][Full Text] [Related]
14. BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.
Laubscher D; Gryder BE; Sunkel BD; Andresson T; Wachtel M; Das S; Roschitzki B; Wolski W; Wu XS; Chou HC; Song YK; Wang C; Wei JS; Wang M; Wen X; Ngo QA; Marques JG; Vakoc CR; Schäfer BW; Stanton BZ; Khan J
Nat Commun; 2021 Nov; 12(1):6924. PubMed ID: 34836971
[TBL] [Abstract][Full Text] [Related]
15. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
16. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
[TBL] [Abstract][Full Text] [Related]
17. MiRNAs as Players in Rhabdomyosarcoma Development.
Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of impaired differentiation in rhabdomyosarcoma.
Keller C; Guttridge DC
FEBS J; 2013 Sep; 280(17):4323-34. PubMed ID: 23822136
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.
Gasparini P; Casanova M; Villa R; Collini P; Alaggio R; Zin A; Bonvini P; Antonescu CR; Boldrini R; Caserini R; Moro M; Centonze G; Meazza C; Massimino M; Bergamaschi L; Luksch R; Chiaravalli S; Bisogno G; Zaffaroni N; Daidone MG; Sozzi G; Ferrari A
Oncotarget; 2016 Sep; 7(37):58903-58914. PubMed ID: 27385213
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
